If you’re being treated with injectable drugs for the “wet” form of age-related macular degeneration (AMD), it’s important not to miss your eye doctor visits, suggest the findings of a study in JAMA Ophthalmology that included 1,178 people with AMD, the leading cause of vision loss in people over 50.
All participants were supposed to see their ophthalmologist monthly to receive an intravitreal (into the eye) injection as needed (if there was retinal “wetness”). Compared to participants who made it to all or most of their appointments (every 28 to 35 days on average), those who went 36 to 60 days between visits lost the ability to recognize six more letters on a standard visual acuity chart, on average, over the course of the two-year study. Those who went more than two months between visits lost almost 13 letters more.
